ArticleAntibiotics (Basel, Switzerland)2024
National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for
Aurélien Dinh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2024
this papercites it